Browsing: Slip

Sleep-health company SomnoMed (ASX:SOM) has been in focus as investors weigh a tempered FY26 Revenue outlook, a Leadership change and a new product launch ahead of the company’s full-year results. SomnoMed, which makes oral devices for treating obstructive sleep apnoea (OSA), has been navigating a period of transition